MD Quote, Financials, Valuation and Earnings

Ceres Ventures, Inc. has a net margin of 14.55% compared to Pediatrix Medical Group, Inc.'s net margin of --. Pediatrix Medical Group, Inc.'s return on equity of 20.22% beat Ceres Ventures, Inc.'s return on equity of --.

Pediatrix Medical Group, Inc. has a consensus price target of $22.67, signalling upside risk potential of 5.57%. On the other hand Ceres Ventures, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Pediatrix Medical Group, Inc. has higher upside potential than Ceres Ventures, Inc., analysts believe Pediatrix Medical Group, Inc. is more attractive than Ceres Ventures, Inc..

Pediatrix Medical Group, Inc. has a beta of 0.759, which suggesting that the stock is 24.082% less volatile than S&P 500. In comparison Ceres Ventures, Inc. has a beta of -45.798, suggesting its less volatile than the S&P 500 by 4679.785%.

Pediatrix Medical Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ceres Ventures, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pediatrix Medical Group, Inc. pays -- of its earnings as a dividend. Ceres Ventures, Inc. pays out -- of its earnings as a dividend.

Pediatrix Medical Group, Inc. quarterly revenues are $492.9M, which are larger than Ceres Ventures, Inc. quarterly revenues of --. Pediatrix Medical Group, Inc.'s net income of $71.7M is higher than Ceres Ventures, Inc.'s net income of --. Notably, Pediatrix Medical Group, Inc.'s price-to-earnings ratio is 11.33x while Ceres Ventures, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group, Inc. is 0.95x versus -- for Ceres Ventures, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Encompass Health Corp. has a net margin of 14.55% compared to Pediatrix Medical Group, Inc.'s net margin of 13.1%. Pediatrix Medical Group, Inc.'s return on equity of 20.22% beat Encompass Health Corp.'s return on equity of 24.74%.

Pediatrix Medical Group, Inc. has a consensus price target of $22.67, signalling upside risk potential of 5.57%. On the other hand Encompass Health Corp. has an analysts' consensus of $142.73 which suggests that it could grow by 25.83%. Given that Encompass Health Corp. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe Encompass Health Corp. is more attractive than Pediatrix Medical Group, Inc..

Pediatrix Medical Group, Inc. has a beta of 0.759, which suggesting that the stock is 24.082% less volatile than S&P 500. In comparison Encompass Health Corp. has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.06%.

Pediatrix Medical Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health Corp. offers a yield of 0.64% to investors and pays a quarterly dividend of $0.19 per share. Pediatrix Medical Group, Inc. pays -- of its earnings as a dividend. Encompass Health Corp. pays out 13% of its earnings as a dividend. Encompass Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Pediatrix Medical Group, Inc. quarterly revenues are $492.9M, which are smaller than Encompass Health Corp. quarterly revenues of $1.5B. Pediatrix Medical Group, Inc.'s net income of $71.7M is lower than Encompass Health Corp.'s net income of $202.3M. Notably, Pediatrix Medical Group, Inc.'s price-to-earnings ratio is 11.33x while Encompass Health Corp.'s PE ratio is 20.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group, Inc. is 0.95x versus 1.95x for Encompass Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Elite Health Systems, Inc. has a net margin of 14.55% compared to Pediatrix Medical Group, Inc.'s net margin of --. Pediatrix Medical Group, Inc.'s return on equity of 20.22% beat Elite Health Systems, Inc.'s return on equity of -72.99%.

Pediatrix Medical Group, Inc. has a consensus price target of $22.67, signalling upside risk potential of 5.57%. On the other hand Elite Health Systems, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Pediatrix Medical Group, Inc. has higher upside potential than Elite Health Systems, Inc., analysts believe Pediatrix Medical Group, Inc. is more attractive than Elite Health Systems, Inc..

Pediatrix Medical Group, Inc. has a beta of 0.759, which suggesting that the stock is 24.082% less volatile than S&P 500. In comparison Elite Health Systems, Inc. has a beta of 0.465, suggesting its less volatile than the S&P 500 by 53.5%.

Pediatrix Medical Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elite Health Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pediatrix Medical Group, Inc. pays -- of its earnings as a dividend. Elite Health Systems, Inc. pays out -- of its earnings as a dividend.

Pediatrix Medical Group, Inc. quarterly revenues are $492.9M, which are larger than Elite Health Systems, Inc. quarterly revenues of --. Pediatrix Medical Group, Inc.'s net income of $71.7M is higher than Elite Health Systems, Inc.'s net income of -$1.2M. Notably, Pediatrix Medical Group, Inc.'s price-to-earnings ratio is 11.33x while Elite Health Systems, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group, Inc. is 0.95x versus 7.08x for Elite Health Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

U.S. Physical Therapy, Inc. has a net margin of 14.55% compared to Pediatrix Medical Group, Inc.'s net margin of 9.98%. Pediatrix Medical Group, Inc.'s return on equity of 20.22% beat U.S. Physical Therapy, Inc.'s return on equity of 8.6%.

Pediatrix Medical Group, Inc. has a consensus price target of $22.67, signalling upside risk potential of 5.57%. On the other hand U.S. Physical Therapy, Inc. has an analysts' consensus of $105.33 which suggests that it could grow by 19.51%. Given that U.S. Physical Therapy, Inc. has higher upside potential than Pediatrix Medical Group, Inc., analysts believe U.S. Physical Therapy, Inc. is more attractive than Pediatrix Medical Group, Inc..

Pediatrix Medical Group, Inc. has a beta of 0.759, which suggesting that the stock is 24.082% less volatile than S&P 500. In comparison U.S. Physical Therapy, Inc. has a beta of 1.297, suggesting its more volatile than the S&P 500 by 29.702%.

Pediatrix Medical Group, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. U.S. Physical Therapy, Inc. offers a yield of 2.04% to investors and pays a quarterly dividend of $0.45 per share. Pediatrix Medical Group, Inc. pays -- of its earnings as a dividend. U.S. Physical Therapy, Inc. pays out 95.62% of its earnings as a dividend. U.S. Physical Therapy, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Pediatrix Medical Group, Inc. quarterly revenues are $492.9M, which are larger than U.S. Physical Therapy, Inc. quarterly revenues of $197.1M. Pediatrix Medical Group, Inc.'s net income of $71.7M is higher than U.S. Physical Therapy, Inc.'s net income of $19.7M. Notably, Pediatrix Medical Group, Inc.'s price-to-earnings ratio is 11.33x while U.S. Physical Therapy, Inc.'s PE ratio is 37.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group, Inc. is 0.95x versus 1.76x for U.S. Physical Therapy, Inc.. Usually stocks with elevated PS ratios are considered overvalued.